GENSIGHT BIOLOGICS S.A. |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3945 EUR | -1.87% |
|
-1.13% | -14.24% |
| Apr. 05 | GenSight: financial visibility assured until the end of April | CF |
| Mar. 25 | GenSight: share price falls, limited financial visibility | CF |
Evolution of the average Target Price on GenSight Biologics S.A.
Price target over the last 5 years
History of analyst recommendation changes
0.4HyosCnjwKugUKKOoaZ8KK-CSwRtMllaj-oreOp-QcM.tC7rhhCglfLKEuq80fIIZe7LJGkuWTIAwZ0YIJA4GIaJTJjgQbWN85UkzQ~9ab03eb23b143063335d54351963d90a
Analysts' Consensus
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
0.402
EUR
Average target price
0.4
EUR
Spread / Average Target
-0.50%
High Price Target
0.4
EUR
Spread / Highest target
-0.50%
Low Price Target
0.4
EUR
Spread / Lowest Target
-0.50%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- SIGHT Stock
- Consensus GenSight Biologics S.A.
